Compounds III-V and their ribofuranosides have been screened for antimicrobial and antifungal evaluations.
Introduction
As a part of large number of therapeutic drugs, the pyrido [2,3-d] pyrimidine have been reported in this paper. These derivatives have manifold implications, such as antifungal [1] [2] [3] [4] , antibacterial [5] [6] [7] [8] [9] , antiallergic 10 and antiherpes 11 etc. The ribofuranosides of pyrido [2,3-d] pyrimidines have been reported as potential antitumor 12 and anti AIDS agents 13 . The promising multifold exploitations of pyrido [2,3-d] pyrimidines and our interest in this area prompted us to synthesize some new pyrido [2,3-d] pyrimidines and their ribofuranosides. These derivatives in antibacterial and antifungal studies have shown promising biological activities.
Experimental
Melting points were determined in capillary tubes and are uncorrected. Infrared spectra were recorded on a SHIMADZU F.T.-IR spectrophotometer using in KBr discs and 1 H NMR spectra on JEOL AL-300 NMR spectrophotometer in CdCl 3 /DMSO.d 6 using TMS as an internal standard. The purity of the synthesized compounds was checked by TLC using Silica gel G as absorbent and visualization was carried out by UV light or iodine.
Synthesis of 2-amino-3-cyano-4,6-disubstituted pyridine II(a-d)
Chalcone (I) (0.05 mole), malononitrile (0.05 mole) and ammonium acetate (0.36 mole) in ethanol (80 mL) were refluxed on a water bath for 15-20 h. After cooling, the contents of the flask were poured into crushed ice with constant stirring to obtain a solid mass, which was washed with water and cold ethanol. The residue was recrystallized from ethanol.
Synthesis of 4-amnio-5,7-disubstituted pyrido[2,3-d]pyrimidine-2(1H)-thiones III(a-d)
A mixture of 2-amino-4,6-disubstituted pyridine (II) (0.01 mole) and thiourea (0.02 mole) was heated on an oil bath at 120-135 o C for 2 h with constant stirring. The temperature was raised to 180 o C and finally the mixture was heated to 220 o C for 2 h. The residue was washed with water, NaHCO 3 solution and finally with cold ethanol. The crude product was recrystallized from DMF: ethanol (1:2). [2,3-d] [2,3- [2,3-d] 
4-Amino-5-(4-methylphenyl)-7-(4-methoxyphenyl)pyrido

4-Amino-5-(4-methylphenyl)-7-(4-chlerophenyl)pyrido[2,3-d]pyrimidine-2(1H)-thione (IIIb)
Yield
4-Amino-5-(4-methylphenyl)-7-(4-bromophenyl)pyrido
4-Amino-5-(2-methylphenyl)-7-(4-methoxyphenyl) pyrido
Synthesis of 4-amino-5,7-disubstituted pyrido[2,3-d]pyrimidine IV(a-d)
Compound II (0.01 mole) and formamide (0.04 mole) were refluxed on an oil bath for 14 hours. After cooling the reaction mixture was poured in to the crushed ice, solid product obtained, was washed with water, dried and recrystallized with ethanol. [2,3-d] [2,3-d] [2,3-d] 
4-Amino-5-(4-methylphenyl)-7-(4-methoxyphenyl)pyrido
4-Amino-5-(4-methylphenyl)-7-(4-chlorophenyl)pyrido
4-Amino-5-(4-methylphenyl)-7-(4-bromophenyl) pyrido
Synthesis of 4-imino-3,5,7-trisubstituted pyrido[2,3-d] pyrimidin-2(1H)-ones V(a-d)
A mixture of compound II (0.01 mole), appropriate arylisocyanate (0.01mole), dioxane (15 mL) and pyridine (2 mL) was heated, reflux at 150 o C for 20-22 hours. The reaction mixture after cooling dropped in to crushed ice with constant stirring to obtained the yellow solid mass which filtered, washed with water and recrystallized from DMF: ethanol (1:2) 
4-Imino-3-(3-chlorophenyl)-5-(4-methylphenyl)-7-(4-methoxyphenyl)pyrido[2,3-d] pyrimidin-2(1H)-one (Va)
4-Imino-3-(3-chlorophenyl)-5-(4-methylphenyl)-7-(4-chlorophenyl)pyrido[2,3-d] pyrimidin-2(1H)-one (Vb)
4-Imino-3-(3-chlorophenyl)-5-(4-methylphenyl)-7-(4-bromophenyl)pyrido[2,3-d] pyrimidin-2(1H)-one (Vc)
4-Imino-3-(3-chlorophenyl)-5-(2-chlorophenyl)-7-(4-methoxyphenyl)pyrido[2,3-d] pyrimidin-2(1H)-one (Vd)
Synthesis of 4-amino-5,7-disubstituted-1-(2′,3′,5′-tri-O-benzoyl-β-D-ribofuranosyl) pyrido[2,3-d]pyrimidine-2(1H)-thione VI(a-d) and 4-imino-3,5,7-trisubstituted-1-(2′,3′,5′-tri-O-benzoyl-β-D-ribofuranosyl) pyrido[2,3-d]pyrimidin-2(1H)-one VII (a-d)
Compound III / V (0.002 mole) in toluene (30 mL) was reacted with hexamethyldislazane (0.012 mole) in presence of ammonium sulphate. The contents were refluxed for 4 hours. The clear solution when obtained was filtered and the solvent was removed in vacuo at 100 o C. The sugar viz. β-D-ribofuranose-1-acetate-2,3,5-tribenzoate (0.002 mole) was added to the above pasty mixture and the contents were stirred, at 155-160 o C under. The reaction mixture was stirred for 10 h and during the reaction period vacuum was regularly applied for five minutes, at the end of every one-hour. The melt was boiled in methanol for 10 minutes, cooled and filtered. The viscous mass of the ribofuranoside so obtained, was recrystallized from diethyl ether. Amino-5-(4-methylphenyl)-7-(4-chlorophenyl)-1-(2′,3′,5′-tri-O-benzoyl-β-D 
4-Amino-5-(4-methylphenyl)-7-(4-methoxyphenyl)-1-(2′,3′,5′-tri-O-benzoyl-β-Drebofuranosyl) pyrido[2,3-d]pyrimidine-2-thione (VI a)
4-
4-Amino-5-(4-methylphenyl)-7-(4-bromophenyl)-1-(2′,3′,5′-tri-O-benzoyl-β-Drebofuranosyl) pyrido[2,3-d]pyrimidine-2-thione (VI c)
4-Amino-5-(2-chlorophenyl)-7-(4-methoxyphenyl)-1-(2′,3′,5′-tri-O-benzoyl-β-Drebofuranosyl) pyrido[2,3-d]pyrimidine-2-thione (VI d)
4-Imino-3-(3-chlorophenyl)-5-(4-methylphenyl)-7-(4-methoxyphenyl)-1-(2′,3′,5′-tri-O-benzoyl-β-D-rebofuranosyl) pyrido[2,3-d]pyrimidin-2-one (VIIa)
4-Imino-3-(3-chlorophenyl)-5-(4-methylphenyl)-7-(4-chlorophenyl)-1-(2′,3′,5′-tri-O-benzoyl-β-D-rebofuranosyl) pyrido[2,3-d]pyrimidin-2-one (VIIb)
4-Imino-3-(3-chlorophenyl)-5-(4-methylphenyl)-7-(4-bromophenyl)-1-(2′,3′,5′-tri-O-benzoyl-β-D-rebofuranosyl) pyrido[2,3-d]pyrimidin-2-one (VIIc)
4-Imino-3-(3-chlorophenyl)-5-(2-chlorophenyl)-7-(4-methoxyphenyl)-1-(2′,3′,5′-tri-O-benzoyl-β-D-rebofuranosyl) pyrido[2,3-d]pyrimidin-2-one (VIId)
Results and Discussion
Chalcone (I) were synthesized by refluxing a suitable acetophenone with substituted benzaldehyde in water-ethanol containing sodium hydroxide. These chalcones (I), on condensation with malanonitrile in ethanol, in presence of ammonium acetate, gave 2-amino-3-cyano-4,6-disubstituted pyridines (II). Compound II on treatment with thiouera, Some New Pyrido [2,3- 
Infrared studies
The IR spectra of 2-amino-3-cyano-4,6-disubstituted pyrimidines II showed-CN and -NH 2 bands of moderate intensity in the region 2280-2180 cm -1 and 3430-3310 cm -1 , respectively. Compound III showed sharp band due to >C=S and three characteristic bands of medium intensity due to >NHCS moiety in the region 1225-1255 cm -1 and 1350-1520 cm -1 , respectively. Compound III also showed band due to -NH 2 and >NH groups in the region 3435-3310 cm -1 and 3155-3200 cm -1 , respectively. In compound IV, -NH 2 band appeared at 3445-3190 cm -1 . >C=O band in compound V was obtained in the region 1700-1660 cm -1 . The new band appeared in compound VI and VII at 1710-1750 cm -1 due to >C=O group and >NH band disappeared in the IR-spectra of these compounds confirmed the ribosilation at this position. The symmetric and asymmetric stretching vibration due to the C-O-C linkage in compound VI and VII have appeared in the region 1165-1025 cm -1 . 
Screening for antimicrobial activities
Antimicrobial evaluations of all the synthesized compounds were carried out against Escherichia coli (gram negative bacteria), Staphylococcus aureus (gram positive bacteria) and fungi e.g. Aspergillius niger, Aspergillus flavus. These compounds were tested at conc. 100 µg/disc in agar-agar media following the method due to Bauer et al 14 . These results have been tabulated in the form of inhibition zones (mm) and activity indices (inhibition area of sample/inhibition area of the standard). Streptomycin and Mycostain were taken as the reference compounds in the antibacterial and antifungal activities, respectively. Comparison of activity indices show that the ribofuranosides i.e. VI and VII show better activities then corresponding precursor heterocylic compounds III and V. All the compounds were found to be moderately active against various bacteria and fungi but compound IIIa was significantly active against gram negative bacteria Escherichia coli. The results of antimicrobial evaluations have been presented in Table 2 . 
